$ADMP Experimental Oral Drug Tempol Has Anti-Covid Potential Fox News: NIH Finds Potential Coronavirus Oral Antiviral Drug The National Institutes of Health (NIH) on Thursday announced a potential oral antiviral treatment to lessen the severity of COVID-19 disease, ahead of clinical studies assessing efficacy in patients. Researchers said the experimental drug, TEMPOL, showed promise in cell cultures by impacting the virus’ ability to replicate, or impairing an enzyme called RNA replicase. Findings were published in the journal Science. "We urgently need additional effective, accessible treatments for COVID-19," Dr. Diana W. Bianchi, National Institute of Child Health and Human Development (NICHD) director, said in a statement posted Thursday. "An oral drug that prevents SARS-CoV-2 from replicating would be an important tool for reducing the severity of the disease." (Rivas, 6/3) khn.org/morning-breakout/ex...
View original message